Filing Details
- Accession Number:
- 0001209191-10-014275
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-03-03 12:00:00
- Reporting Period:
- 2010-03-01
- Filing Date:
- 2010-03-03
- Accepted Time:
- 2010-03-03 19:38:28
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1333170 | Nxstage Medical Inc. | NXTM | Electromedical & Electrotherapeutic Apparatus (3845) | 043454702 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1341405 | L Winifred Swan | C/O Nxstage Medical, Inc. 439 South Union Street, 5Th Floor Lawrence MA 01843 | Svp And General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2010-03-01 | 25,555 | $2.74 | 47,985 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2010-03-01 | 3,656 | $3.76 | 51,641 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2010-03-01 | 29,211 | $10.63 | 22,430 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2010-03-01 | 25,555 | $0.00 | 25,555 | $2.74 |
| Common Stock | Stock Option (right to buy) | Disposition | 2010-03-01 | 3,656 | $0.00 | 3,656 | $3.76 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2000-11-27 | 2010-11-27 | No | 4 | M | Direct |
| 0 | 2001-08-22 | 2011-08-21 | No | 4 | M | Direct |
Footnotes
- The shares sold underlying the options exercised were with respect to options scheduled to expire in 2010 and 2011. As such, the bulk of the shares underlying such options would have otherwise been forfeited in 2010, with a small remainder forfeited in 2011.
- The shares were sold in multiple transactions on March 1, 2010 at an actual purchase price ranging from $10.5975 to $10.69 per share. The price reported reflects the weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
- This stock option was fully exercisable on the date of grant.
Billionaire Hedge Funds
